|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
92:1218-1221
(1995)
|
|
PubMed id:
|
|
|
|
|
| |
|
The three-dimensional structure of a class I major histocompatibility complex molecule missing the alpha 3 domain of the heavy chain.
|
|
E.J.Collins,
D.N.Garboczi,
M.N.Karpusas,
D.C.Wiley.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Class I major histocompatibility complex (MHC) molecules are ternary complexes
of the soluble serum protein beta 2-microglobulin, MHC heavy chain, and bound
peptide. The first two domains (alpha 1, alpha 2) of the heavy chain create the
peptide binding cleft and the surface that contacts the T-cell receptor. The
third domain (alpha 3) associates with the T-cell co-receptor, CD8, during
T-cell recognition. Here we describe the x-ray crystal structure of a human
class I MHC molecule, HLA-Aw68, from which the alpha 3 domain has been
proteolytically removed. The resulting molecule shows no gross morphological
changes compared to the intact protein. A decameric peptide complexed with the
intact HLA-Aw68 is seen to bind to the proteolized molecule in the conventional
manner, demonstrating that the alpha 3 domain is not required for the structural
integrity of the molecule or for peptide binding.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.Nojima,
M.Takeda-Shitaka,
K.Kanou,
K.Kamiya,
and
H.Umeyama
(2008).
Dynamic interaction among the platform domain and two membrane-proximal immunoglobulin-like domains of class I major histocompatibility complex: normal mode analysis.
|
| |
Chem Pharm Bull (Tokyo),
56,
635-641.
|
 |
|
|
|
|
 |
E.Duprat,
M.P.Lefranc,
and
O.Gascuel
(2006).
A simple method to predict protein-binding from aligned sequences--application to MHC superfamily and beta2-microglobulin.
|
| |
Bioinformatics,
22,
453-459.
|
 |
|
|
|
|
 |
T.Blicher,
J.S.Kastrup,
L.Ã.˜.Pedersen,
S.Buus,
and
M.Gajhede
(2006).
Structure of HLA-A*1101 in complex with a hepatitis B peptide homologue.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun,
62,
1179-1184.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.E.Tynan,
S.R.Burrows,
A.M.Buckle,
C.S.Clements,
N.A.Borg,
J.J.Miles,
T.Beddoe,
J.C.Whisstock,
M.C.Wilce,
S.L.Silins,
J.M.Burrows,
L.Kjer-Nielsen,
L.Kostenko,
A.W.Purcell,
J.McCluskey,
and
J.Rossjohn
(2005).
T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.
|
| |
Nat Immunol,
6,
1114-1122.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Blicher,
J.S.Kastrup,
S.Buus,
and
M.Gajhede
(2005).
High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide.
|
| |
Acta Crystallogr D Biol Crystallogr,
61,
1031-1040.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Nojima,
M.Takeda-Shitaka,
Y.Kurihara,
K.Kamiya,
and
H.Umeyama
(2003).
Dynamic flexibility of a peptide-binding groove of human HLA-DR1 class II MHC molecules: normal mode analysis of the antigen peptide-class II MHC complex.
|
| |
Chem Pharm Bull (Tokyo),
51,
923-928.
|
 |
|
|
|
|
 |
P.E.Adrian,
G.Rajaseger,
V.S.Mathura,
M.K.Sakharkar,
and
P.Kangueane
(2002).
Types of inter-atomic interactions at the MHC-peptide interface: identifying commonality from accumulated data.
|
| |
BMC Struct Biol,
2,
2.
|
 |
|
|
|
|
 |
M.García-Peydró,
D.Rognan,
and
J.A.López de Castro
(2000).
Limited plasticity in the recognition of peptide epitope variants by an alloreactive CTL clone correlates directly with conservation of critical residues and inversely with peptide length.
|
| |
Tissue Antigens,
55,
289-295.
|
 |
|
|
|
|
 |
O.Schueler-Furman,
Y.Altuvia,
A.Sette,
and
H.Margalit
(2000).
Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles.
|
| |
Protein Sci,
9,
1838-1846.
|
 |
|
|
|
|
 |
K.Maenaka,
and
E.Y.Jones
(1999).
MHC superfamily structure and the immune system.
|
| |
Curr Opin Struct Biol,
9,
745-753.
|
 |
|
|
|
|
 |
E.J.Collins,
and
J.A.Frelinger
(1998).
Altered peptide ligand design: altering immune responses to class I MHC/peptide complexes.
|
| |
Immunol Rev,
163,
151-160.
|
 |
|
|
|
|
 |
E.Y.Jones
(1997).
MHC class I and class II structures.
|
| |
Curr Opin Immunol,
9,
75-79.
|
 |
|
|
|
|
 |
M.A.Batalia,
and
E.J.Collins
(1997).
Peptide binding by class I and class II MHC molecules.
|
| |
Biopolymers,
43,
281-302.
|
 |
|
|
|
|
 |
D.H.Fremont,
W.A.Rees,
and
H.Kozono
(1996).
Biophysical studies of T-cell receptors and their ligands.
|
| |
Curr Opin Immunol,
8,
93.
|
 |
|
|
|
|
 |
K.J.Smith,
S.W.Reid,
D.I.Stuart,
A.J.McMichael,
E.Y.Jones,
and
J.I.Bell
(1996).
An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501.
|
| |
Immunity,
4,
203-213.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.C.Solheim,
J.R.Cook,
and
T.H.Hansen
(1995).
Conformational changes induced in the MHC class I molecule by peptide and beta 2-microglobulin.
|
| |
Immunol Res,
14,
200-217.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |